Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 1
2005 1
2006 1
2007 5
2008 7
2009 5
2010 4
2011 5
2012 7
2013 3
2014 9
2015 5
2016 5
2017 10
2018 4
2019 3
2020 6
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
The EUROclass trial: defining subgroups in common variable immunodeficiency.
Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debré P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, Vihinen M, Oksenhendler E, Peter HH, Warnatz K. Wehr C, et al. Among authors: jacobs r. Blood. 2008 Jan 1;111(1):77-85. doi: 10.1182/blood-2007-06-091744. Epub 2007 Sep 26. Blood. 2008. PMID: 17898316 Free article.
Management of MS-relapse during alemtuzumab therapy: Is it really B-cell-mediated?
Schwenkenbecher P, Deppe J, Hümmert MW, Jacobs R, Bronzlik P, Stangel M, Skripuletz T. Schwenkenbecher P, et al. Among authors: jacobs r. Mult Scler Relat Disord. 2018 Jan;19:6-7. doi: 10.1016/j.msard.2017.10.014. Epub 2017 Oct 22. Mult Scler Relat Disord. 2018. PMID: 29158120 No abstract available.
Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1.
Schröder C, Sogkas G, Fliegauf M, Dörk T, Liu D, Hanitsch LG, Steiner S, Scheibenbogen C, Jacobs R, Grimbacher B, Schmidt RE, Atschekzei F. Schröder C, et al. Among authors: jacobs r. Front Immunol. 2019 Nov 14;10:2618. doi: 10.3389/fimmu.2019.02618. eCollection 2019. Front Immunol. 2019. PMID: 31803180 Free PMC article.
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.
Möhn N, Wattjes MP, Adams O, Nay S, Tkachenko D, Salge F, Heine J, Pars K, Höglinger G, Respondek G, Stangel M, Skripuletz T, Jacobs R, Sühs KW. Möhn N, et al. Among authors: jacobs r. Ther Adv Neurol Disord. 2021 Mar 9;14:1756286421993684. doi: 10.1177/1756286421993684. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34035834 Free PMC article.
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs KW, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, Alvermann S, Schmidt RE, Stangel M, Jacobs R, Skripuletz T. Gingele S, et al. Among authors: jacobs r. Cells. 2018 Dec 28;8(1):12. doi: 10.3390/cells8010012. Cells. 2018. PMID: 30597851 Free PMC article.
Detection and quantification of rituximab in the human urine.
Jacobs R, Langer-Jacobus T, Duong M, Stahl K, Haller H, Schmidt RE, Schiffer M. Jacobs R, et al. J Immunol Methods. 2017 Dec;451:118-121. doi: 10.1016/j.jim.2017.09.001. Epub 2017 Sep 7. J Immunol Methods. 2017. PMID: 28890365
79 results